In re: Andrea Sherman, et al v. Securities and Exchange Commi | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for In re: Andrea Sherman, et al v. Securities and Exchange Commi

Sort by

Viewing results 1‒6 of 6

FTfmJohn Dizard
What is the true value of Burford’s $773m claim against YPF?
...For example, in a 2010 opinion (Chevron Corp v Steven Donziger, et al) handed down from the US district court in Manhattan, the judge wrote that the “evidence at trial established that Donziger, a New York...
May 1, 2020
FT AlphavilleDavid Keohane
This isn’t the Chinese capital account liberalisation you’re looking for
...chart from Cap Econ attempting to summarise China’s current position from a purely economic standpoint: And an extra large chart covering RMB promotion from Xi et al from Deutsche for those who can be bothered...
July 17, 2015
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
FT AlphavilleSujeet Indap
Beta max
...For a company like Rural that is traded on a major exchange, ―[t]urnover measured by average weekly trading of . . . 1% would justify a substantial presumption‖ of market efficiency. 5 Bromberg et al., Bromberg...
June 19, 2015
FT AlphavilleJoseph Cotterill
A eurozone safe against, or is it safe for, sovereign holdouts? Part two
...exchange deal) have an interest in an orderly restructuring....
February 19, 2013
FT AlphavilleJoseph Cotterill
“Repent, Argentina!” said the ticktock judges (part one)
...Again, it was all a bit vague in the courtroom, but one idea seemed to be giving NML et al whatever the backlog of 11 years of payments was, and then paying them at the EBG rate thereafter....
March 2, 2013
FT AlphavilleIzabella Kaminska
On the ECB’s ‘most significant non-standard measure’
...According to Cassola et al. (2009), banks submitted more aggressive bids in order to make sure that they receive at least a minimum level of liquidity....
December 8, 2011
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA

Previous pagePage 1 of 1Next page